Abstract
In 1990 the first Fulda Workshop on Glycogen Storage Disease (GSD) type I was held in November. Eight adult representatives from Patient groups in the UK, USA, Germany and the Netherlands were invited to come and set up an information table of posters, leaflets etc. We were also asked to present a short list of questions that can occur to parents after the initial shock of diagnosis and treatment of GSD has been made. These “Questions of Parents” were presented on the final day. Ten years later, patient representatives from Europe were invited to present “More Questions: 10 Years Later”. On both occasions the questions centred around six broad areas: (1) treatments, (2) specific problems, (3) family planning, (4) long-term effects of having GSD type Ia and Ib, (5) research and (6) general questions.Conclusion: As representatives of GSD support groups, we hope that firm decisions can be agreed for common dietary and pharmacological treatment and follow-up procedures within the boundaries of cultural differences and financial circumstances. We anticipate that if there is a third Fulda workshop in 2010, the answer to the question “Is there a common set of protocols and guidelines among doctors and hospitals as to the correct treatment for glycogen storage disease type I?” will be a firm “Yes”.
Similar content being viewed by others
Abbreviations
- G-CSF :
-
granulocyte colony-stimulating factor
- GSD :
-
glycogen storage disease
- NGF :
-
nasogastric feeding
- GF :
-
gastrostomy feeding
- UCS :
-
uncooked cornstarch
- G6Pase :
-
glucose-6-phosphatase
References
Beaty RM, Jackson M, Peterson D, Bird A, Brown T, Benjamin DK Jr, Juopperi T, Kishnani P, Boney A, Chen YT, Koeberl DD (2002) Delivery of glucose-6-phosphatase in a canine model of glycogen storage disease, type la, with adeno-associated virus (AAV) vectors. Gene Ther 9: 1015–1022
Chen YT, Cornblath M, Sidbury JB (1984) Cornstarch therapy in type I glycogen storage disease. N Engl J Med 310: 171–175
Smit GPA (1993) The long-term outcome of patients with glycogen storage disease type Ia. Eur J Pediatr 152[Suppl I]: S52-S55
Wolfsdorf JI, Holm IA, Weinstein DA (1999) Glycogen storage diseases. Phenotypic, genetic and biochemical characteristics and therapy. Endocrinol Metab Clin North Am 28: 801–823
The Metabolic & Molecular Bases of Inherited Diseases, 1995 Seventh edition, Chapter 24. The Glycogen Storage Diseases, Y.T. Chen & A. Burchell
Author information
Authors and Affiliations
Additional information
Published online: 4 September 2002
Rights and permissions
About this article
Cite this article
Phillips, A. More questions: 10 years later from glycogen storage disease patient support groups in Europe. Eur J Pediatr 161, S102–S105 (2002). https://doi.org/10.1007/BF02680005
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02680005